Product NDC: | 55111-468 |
Proprietary Name: | Metoprolol succinate |
Non Proprietary Name: | Metoprolol succinate |
Active Ingredient(s): | 100 mg/1 & nbsp; Metoprolol succinate |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET, EXTENDED RELEASE |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 55111-468 |
Labeler Name: | Dr. Reddy's Laboratories Limited |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA078889 |
Marketing Category: | ANDA |
Start Marketing Date: | 20120910 |
Package NDC: | 55111-468-05 |
Package Description: | 500 TABLET, EXTENDED RELEASE in 1 BOTTLE (55111-468-05) |
NDC Code | 55111-468-05 |
Proprietary Name | Metoprolol succinate |
Package Description | 500 TABLET, EXTENDED RELEASE in 1 BOTTLE (55111-468-05) |
Product NDC | 55111-468 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Metoprolol succinate |
Dosage Form Name | TABLET, EXTENDED RELEASE |
Route Name | ORAL |
Start Marketing Date | 20120910 |
Marketing Category Name | ANDA |
Labeler Name | Dr. Reddy's Laboratories Limited |
Substance Name | METOPROLOL SUCCINATE |
Strength Number | 100 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Adrenergic beta-Antagonists [MoA],beta-Adrenergic Blocker [EPC] |